Clinical Trial Update: A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease

View source ↗

Summary

This clinical trial update reports on a pharmacokinetic–pharmacodynamic modeling and simulation study of subcutaneous infliximab in patients with inflammatory b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Erwin Dreesen | Conditions: IBD - Inflammatory Bowel Disease, RA - Rheumatoid Arthritis | Status: NOT_YET_RECRUITING